Another study of RIS patients showed that although definite MS, including individuals with both PPMS and RRMS, can be distinguished from RIS with the use of NfL levels in CSF, CSF levels were similar for RIS, CIS, and early MS patients [82]. This evidence concerns the gene NEFL and in situ carcinoma.